| Research Article |  |
Open Access |  |
Open Peer Review |
FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding Puts Patients at Risk: How to protect and advance the public health through more robust regulatory oversight and timely legislative action
|
|
|
||
Downloads |
Comments |
Views |
|
Abstract |
|
|
1. FDA Approval System: The Gold Standard For Safety and Quality |
|
|
2. Failures in Enforcing The Limits on Compounders Puts Patients At Risk |
|
|
3. Calls To Action to Protect American Patients |
|
|
4. Conclusion |
|
|
References |
Reader Comments
Comment
We welcome and encourage comments from both scientists and the general public. Comments are moderated solely for appropriateness and will be posted after review.